Profile data is unavailable for this security.
About the company
abrdn Life Sciences Investors (the Fund), formerly Tekla Life Sciences Investors, is a non-diversified closed-end management investment company. The Fund's investment objective is long-term capital appreciation through investment in United States and foreign companies in the life sciences industry, including biotechnology, pharmaceutical, diagnostics, managed healthcare and medical equipment, hospitals, healthcare information technology and services, devices and supplies, and agriculture and environmental management. The Fund invests primarily in securities of public and private companies, which have the potential for above-average growth. The Fund invests up to 20% of its net assets in securities of foreign issuers, expected to be located primarily in Western Europe, Canada and Japan, and securities of United States issuers that are traded primarily in foreign markets. The Fund's investment adviser is abrdn Inc.
- Revenue in USD (TTM)3.63m
- Net income in USD38.81m
- Incorporated1992
- Employees--
- Locationabrdn Life Sciences Investors1900 Market Street, Suite 200PHILADELPHIA 19103United StatesUSA
- Phone+1 (617) 772-8515
- Websitehttps://www.teklacap.com/funds/hql/fund/fund-information/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allspring Income Opportunities Fund | 45.74m | 38.34m | 398.87m | -- | 10.34 | 0.9378 | -- | 8.72 | 0.6527 | 0.6527 | 0.7741 | 7.20 | 0.0733 | -- | 3.24 | -- | 6.14 | 2.69 | 6.24 | 2.74 | 65.52 | 75.31 | 83.81 | 43.54 | -- | -- | 0.3077 | 219.97 | 10.25 | -1.98 | 478.26 | 0.8261 | -- | -2.73 |
| BlackRock MuniYield NewYork Qlty Fnd Inc | -100.00bn | -100.00bn | 400.76m | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| First Trust Enhanced Equity Income Fund | 7.06m | 66.24m | 402.16m | -- | 6.07 | 1.07 | -- | 56.99 | 3.31 | 3.31 | 0.353 | 18.74 | 0.0197 | -- | 2.05 | -- | 18.45 | -- | 18.71 | -- | 41.87 | -- | 938.68 | -- | -- | -- | 0.00 | -- | 0.0882 | -- | 196.50 | -- | -- | -- |
| Flaherty & Crumrine Dynmc Prf&Inm Fd Inc | 46.73m | 8.96m | 402.34m | -- | 44.93 | 0.9945 | -- | 8.61 | 0.4361 | 0.4361 | 2.28 | 19.70 | 0.0673 | -- | 6.48 | -- | 1.29 | 2.67 | 1.29 | 2.67 | 55.68 | 72.92 | 19.16 | 44.32 | -- | 1.53 | 0.4058 | 175.51 | 2.38 | 1.37 | 110.36 | -- | -- | -4.17 |
| Eaton Vance Tax-Managed Buy-Wrte Incm Fd | 7.18m | 65.35m | 416.24m | 0.00 | 6.37 | 0.9972 | -- | 58.01 | 2.22 | 2.22 | 0.2443 | 14.21 | 0.0177 | -- | 9.17 | -- | 16.08 | 8.35 | 16.12 | 8.37 | 43.19 | 45.13 | 910.76 | 470.07 | -- | -- | 0.00 | 93.17 | -2.53 | -3.18 | 207.42 | -- | -- | -5.72 |
| Eaton Vance Municipal Income Trust | 28.73m | 13.29m | 416.90m | 0.00 | 31.37 | 0.9458 | -- | 14.51 | 0.335 | 0.335 | 0.7244 | 11.11 | 0.0443 | -- | 4.62 | -- | 2.05 | 1.07 | 2.06 | 1.08 | 59.03 | 68.14 | 46.25 | 26.69 | -- | 4.80 | 0.2799 | 255.01 | -2.97 | 4.12 | 113.85 | 47.65 | -- | -5.48 |
| Highland Opportunities and Income Fund | 55.78m | -14.09m | 417.42m | -- | -- | 0.4897 | -- | 7.48 | -0.2054 | -0.2054 | 0.8167 | 14.79 | 0.0514 | -- | 2.29 | -- | -1.30 | 3.25 | -1.34 | 3.40 | 77.31 | 75.30 | -25.25 | 54.33 | -- | 0.7107 | 0.0267 | 154.10 | -47.15 | -- | -145.58 | -- | -- | -- |
| abrdn Life Sciences Investors | 3.63m | 38.81m | 420.38m | -- | 10.83 | 0.9531 | -- | 115.65 | 1.42 | 1.42 | 0.1329 | 16.13 | 0.0083 | -- | 59.13 | -- | 8.87 | 1.54 | 8.99 | 1.56 | -36.65 | -68.31 | 1,067.62 | 238.14 | -- | -- | 0.00 | 514.01 | 15.89 | 11.99 | 121.37 | -4.85 | -- | -- |
| Voya Global Equity Div and Prem Oppty Fd | 35.01m | 30.48m | 422.74m | -- | 10.20 | 0.9105 | -- | 12.07 | 0.5257 | 0.5257 | 0.7416 | 5.89 | 0.0737 | -- | 13.00 | -- | 6.42 | 4.20 | 6.48 | 4.26 | 88.76 | 83.43 | 87.05 | 81.42 | -- | -- | 0.00 | 132.08 | 204.13 | -- | 339.84 | -- | -- | -8.09 |
| Eaton Vnc Tax-Advtgd Glbl Dvdnd Oppnt Fd | -100.00bn | -100.00bn | 427.89m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Diamond Hill Investment Group Inc | 139.02m | 42.53m | 428.97m | 129.00 | 10.48 | 2.74 | 9.91 | 3.09 | 14.76 | 14.76 | 47.99 | 56.44 | 0.6268 | -- | 6.93 | 1,077,681.00 | 18.93 | 18.77 | 21.19 | 23.82 | 97.62 | 97.72 | 30.21 | 34.42 | -- | -- | 0.00 | 75.69 | -11.51 | -1.25 | 4.43 | -1.89 | -51.17 | -- |
| Advent Convertible and Income Fund | -100.00bn | -100.00bn | 434.15m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Nuveen Multi-Asset Income Fund | 29.68m | 54.87m | 436.87m | -- | 7.96 | 0.9502 | -- | 14.72 | 1.64 | 1.64 | 0.8879 | 13.76 | 0.0444 | -- | 6.96 | -- | 8.21 | -- | 9.38 | -- | 44.18 | -- | 184.88 | -- | -- | -- | 0.2778 | -- | 1.31 | -- | 137.44 | -- | -- | -- |
Data as of Jul 23 2024. Currency figures normalised to abrdn Life Sciences Investors's reporting currency: US Dollar USD
24.67%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Saba Capital Management LPas of 26 Jun 2024 | 3.43m | 12.54% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Mar 2024 | 484.18k | 1.77% |
| 1607 Capital Partners LLCas of 31 Mar 2024 | 481.38k | 1.76% |
| Allspring Global Investments LLCas of 31 Mar 2024 | 431.32k | 1.58% |
| AQR Arbitrage LLCas of 31 Mar 2024 | 387.31k | 1.42% |
| Karpus Management, Inc.as of 31 Mar 2024 | 345.52k | 1.26% |
| RPO LLCas of 31 Mar 2024 | 338.54k | 1.24% |
| Needham Investment Management LLCas of 31 Mar 2024 | 330.23k | 1.21% |
| Flagship Harbor Advisors LLCas of 31 Mar 2024 | 283.83k | 1.04% |
| Merrill Lynch, Pierce, Fenner & Smith, Inc. (Invt Mgmt)as of 31 Mar 2024 | 236.13k | 0.86% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
